Page 135 | Certara

Press Coverage

Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?

By Professor Piet van der Graaf, Ph.D., and Hugo Geerts, Ph.D. Neurodegenerative diseases (NDs) affect…

CertaraMarch 10, 2021

Video

PK Submit CDISC Technology

PK Submit automates the time consuming, error-prone and complex task of creating CDISC domains as…

CertaraMarch 10, 2021

On-Demand Webinar

IQ WG Evaluation of PBPK Models for Organ-Impaired Populations

• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…

CertaraMarch 10, 2021

Brochure

R Speaks NLME (RsNLME)

Download the brochure to learn more about RsNLME’s features and benefits.

CertaraMarch 9, 2021

On-Demand Webinar

Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors

It is crucial for biotech developers to engage in early commercial market assessment to generate…

CertaraMarch 5, 2021

Press Coverage

Scientific Computing World: Connecting Science

Interconnection is an imperative for the modern laboratory, and seamless integration is mandatory from the…

CertaraMarch 4, 2021

White Paper

Advancing Pediatric Drug Development Using Simcyp® PBPK

CertaraMarch 4, 2021

Blog

Controlled Terminology Best Practices

Simplify Controlled Terminology with expert insights from Sarah Angelo. Overcome challenges, ensure compliance, and improve…

CertaraMarch 3, 2021

Case Study

Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software

In 2019, Prelude Therapeutics, a small cancer drug discovery company, implemented Certara’s GlobalSubmit submissions management…

CertaraMarch 2, 2021

On-Demand Webinar

Quantitative Systems Pharmacology for Drug Discovery and Development

Certara's Dr. Piet van der Graaf, Senior Vice President, Professor of Systems Pharmacology, Leiden University,…

CertaraMarch 2, 2021

Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?

PK Submit CDISC Technology

IQ WG Evaluation of PBPK Models for Organ-Impaired Populations

R Speaks NLME (RsNLME)

Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors

Scientific Computing World: Connecting Science

Advancing Pediatric Drug Development Using Simcyp® PBPK

Controlled Terminology Best Practices

Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software

Quantitative Systems Pharmacology for Drug Discovery and Development

Newsletter sign up

Quick links

Solutions

Contact